Cardiac biomarkers predict mortality in emergency patients presenting with atrial fibrillation.
Aged
Atrial Fibrillation
/ blood
Austria
/ epidemiology
Biomarkers
/ blood
Cohort Studies
Emergencies
/ epidemiology
Emergency Service, Hospital
/ statistics & numerical data
Female
Humans
Male
Middle Aged
Mortality
Natriuretic Peptide, Brain
/ blood
Peptide Fragments
/ blood
Predictive Value of Tests
Prognosis
Proportional Hazards Models
Risk Assessment
/ methods
Risk Factors
Troponin T
/ blood
atrial fibrillation
atrial flutter
Journal
Heart (British Cardiac Society)
ISSN: 1468-201X
Titre abrégé: Heart
Pays: England
ID NLM: 9602087
Informations de publication
Date de publication:
03 2019
03 2019
Historique:
received:
09
02
2018
revised:
21
08
2018
accepted:
05
09
2018
pubmed:
12
11
2018
medline:
3
5
2019
entrez:
12
11
2018
Statut:
ppublish
Résumé
To assess the predictive value of N-terminal pro-brain natriuretic peptide (NT-proBNP) and high-sensitive troponin T (hs-TnT) serum levels for mid-term mortality in patients presenting with symptomatic atrial fibrillation (AF) to an emergency department. Non-interventional cohort/follow-up study, including consecutive patients presenting to a tertiary care university emergency department due to symptomatic AF between 2012 and 2016. Multivariable Cox proportional hazard regression models were used to estimate the mortality rates and hazards per 100 patient-years (pry) for NT-proBNP and hs-TnT serum levels in quintiles. 2574 episodes of 1754 patients (age 68 (IQR 58-75) years, female gender 1199 (44%), CHA Elevated NT-proBNP and hs-TnT levels are independently associated with increased mid-term mortality in patients presenting to an emergency department due to symptomatic AF. NCT03272620; Results.
Identifiants
pubmed: 30415208
pii: heartjnl-2018-313145
doi: 10.1136/heartjnl-2018-313145
pmc: PMC6580776
doi:
Substances chimiques
Biomarkers
0
Peptide Fragments
0
Troponin T
0
pro-brain natriuretic peptide (1-76)
0
Natriuretic Peptide, Brain
114471-18-0
Banques de données
ClinicalTrials.gov
['NCT03272620']
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
482-488Informations de copyright
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
J Am Coll Cardiol. 2004 Jan 21;43(2):241-7
pubmed: 14736444
N Engl J Med. 2005 Feb 17;352(7):666-75
pubmed: 15716560
Am Heart J. 2005 Apr;149(4):657-63
pubmed: 15990749
Am Heart J. 2005 Dec;150(6):1220-7
pubmed: 16338262
J Am Coll Cardiol. 2007 May 15;49(19):1943-50
pubmed: 17498579
J Am Coll Cardiol. 2007 Dec 18;50(25):2357-68
pubmed: 18154959
Eur Heart J. 2008 Sep;29(18):2252-8
pubmed: 18606612
N Engl J Med. 2009 Dec 24;361(26):2538-47
pubmed: 19940289
Circulation. 2012 Apr 3;125(13):1605-16
pubmed: 22374183
Eur Heart J. 2013 May;34(20):1475-80
pubmed: 23386711
J Am Coll Cardiol. 2013 Jun 4;61(22):2274-84
pubmed: 23563134
Eur Rev Med Pharmacol Sci. 2013 Dec;17(23):3132-47
pubmed: 24338454
Circ Res. 2014 Apr 25;114(9):1453-68
pubmed: 24763464
J Med Syst. 2016 Jul;40(7):175
pubmed: 27272135
Heart. 2016 Dec 15;102(24):1963-1968
pubmed: 27456261
Eur Heart J. 2016 Oct 7;37(38):2893-2962
pubmed: 27567408
BMC Pulm Med. 2016 Nov 25;16(1):164
pubmed: 27887619
Shock. 2017 Jun;47(6):702-708
pubmed: 27902530
Ann Emerg Med. 2017 May;69(5):562-571.e2
pubmed: 28110987
QJM. 2017 Aug 1;110(8):507-511
pubmed: 28340049
Europace. 2018 Apr 1;20(4):582-588
pubmed: 28460039
Heart. 2017 Dec;103(24):1947-1953
pubmed: 28490616
Heart. 2018 Dec;104(24):2010-2017
pubmed: 29666179
N Engl J Med. 1996 Oct 31;335(18):1342-9
pubmed: 8857017